financetom
Business
financetom
/
Business
/
Pantheon Resources, Alaska LNG developer sign agreement on natural gas sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pantheon Resources, Alaska LNG developer sign agreement on natural gas sales
Jun 4, 2024 3:53 PM

June 4 (Reuters) - Pantheon Resources ( PTHRF ) said on

Tuesday it had signed an agreement establishing the terms for

future sales of its natural gas to a unit of state-backed Alaska

Gasline Development Corporation.

Pantheon subsidiary Great Bear Pantheon entered the

agreement with a unit of AGDC to outline key commercial terms

that will be part of a binding "take-or-pay" deal after AGDC

makes a final investment decision (FID) on a proposed pipeline

from Alaska's North Slope to its Southcentral region.

The pipeline FID is currently planned for the middle of

2025.

The agreement details plans for Pantheon to supply AGDC with

up to 500 million cubic feet per day of natural gas at a maximum

price of $1 per million British Thermal Units (BTU) in current

currency values, the company said. The agreement will have an

initial length of 20 years with the potential for extension

beyond that, it added.

AGDC is a state-owned company developing the Alaska LNG

project, a federally approved liquefied natural gas (LNG) export

plant that could export around 20 million metric tons of LNG per

year starting 2029. Development of the North Slope to

Southcentral pipeline is the first phase of that project.

Pantheon is developing the Ahpun and Kodiak fields in

Alaska, which are estimated to hold close to 5 billion cubic

feet of recoverable natural gas resources, according to the

company.

A final gas sales agreement between AGDC and Pantheon will

depend on the companies making FIDs on both their respective

projects, Pantheon said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved